DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, et al
Many patients on GLP-1s experience muscle atrophy, which can alter body composition and make weight fluctuations more noticeable (and as muscle helps reduce insulin resistance, muscle loss works against health metabolism)
Texture and temperature modifications can improve food tolerance
Cycling: 4-week cycles followed by 4-8 week breaks allow assessment of lasting effects and prevent potential receptor adaptations
Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Ozempic but is customized and typically more affordable
Appetite Regulation: GLP-1 acts on the brains appetite centers to decrease hunger, encouraging healthier eating habits